Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Crane NXT, Co. Director's Dealing 2017

Aug 29, 2017

31213_dirs_2017-08-29_ec4b0b88-2385-4e25-915a-4be37fad3d6a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CRANE CO /DE/ (CR)
CIK: 0000025445
Period of Report: 2017-08-28

Reporting Person: BIGELOW E THAYER (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-28 CRANE CO. COMMON, PAR VALUE $1.00 M 2000 $36.26 Acquired 21791 Indirect
2017-08-28 CRANE CO. COMMON, PAR VALUE $1.00 M 2000 $47.08 Acquired 23791 Indirect
2017-08-28 CRANE CO. COMMON, PAR VALUE $1.00 M 2000 $46.99 Acquired 25791 Indirect
2017-08-28 CRANE CO. COMMON, PAR VALUE $1.00 S 6000 $73.7306 Disposed 19791 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-08-28 Director Stock Option(Right to Buy) $36.26 M 2000 Disposed 2020-04-19 CRANE CO. COMMON, PAR VALUE $1.00 (2000.0) Indirect
2017-08-28 Director Stock Option(Right to Buy) $47.08 M 2000 Disposed 2021-04-18 CRANE CO. COMMON, PAR VALUE $1.00 (2000.0) Indirect
2017-08-28 Director Stock Option(Right to Buy) $46.99 M 2000 Disposed 2022-04-23 CRANE CO. COMMON, PAR VALUE $1.00 (2000.0) Indirect

Footnotes

F1: On March 13, 2017 these options were transferred by Mr. Bigelow to a revocable trust of which he is trustee.

F2: Concurrent sale of shares resulting from an exercise of options granted on 4/19/2010 and expiring on 4/19/2020, exercise of options granted on 4/18/2011 and expiring on 4/18/2021, and exercise of options granted on 4/23/2012 and expiring on 4/23/2022.

F3: This option was granted 4/19/2010 with a ten-year term, and vested 25% each year over four years.

F4: This option was granted 4/18/2011 with a ten-year term, and vested 25% each year over four years.

F5: This option was granted 4/23/2012 with a ten-year term, and vested 25% each year over four years.